Beobachtungsplan, NIS 274: Early MOnitoring of REsponse on therapy of Golimumab (GLM) with fecal calprotectin and trough serum levels in patients with ulcerative colits. A multicentric, prospective study. (MORE-Studie)

Datei

• Artikel "Beobachtungsplan, NIS 274: Early MOnitoring of REsponse on therapy of Golimumab (GLM) with fecal calprotectin and trough serum levels in patients with ulcerative colits. A multicentric, prospective study. (MORE-Studie)"Herunterladen(PDF, 1.005KB, Datei ist nicht barrierefrei)